Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, PA.
J Arthroplasty. 2022 Feb;37(2):226-231.e1. doi: 10.1016/j.arth.2021.10.026. Epub 2021 Nov 3.
Total joint arthroplasty (TJA) surgeons employ various strategies to reduce the risk of periprosthetic joint infection (PJI). Few studies have examined the efficacy of preclosure dilute povidone-iodine irrigation in a large cohort accounting for recent practice changes in TJA. This study compared the risk of PJI in TJA patients with and without dilute povidone-iodine irrigation.
This is a retrospective study of all consecutive primary TJAs between 2009 and 2019 at a single institution. We included 31,331 cases, of which 8659 were irrigated with dilute povidone-iodine and 22,672 were irrigated with sterile saline prior to closure. The primary endpoint was PJI as defined by 2018 International Consensus Meeting criteria with a minimum follow-up of 1 year. Multivariate logistic regression was used to determine the association between dilute povidone-iodine irrigation and PJI while controlling for demographics, comorbidities, and operative factors.
In total, 340 patients (1.09%) developed PJI. Dilute povidone-iodine irrigation was associated with 2.34 times lower rate of PJI (0.6% vs 1.3%). Using multiple regression, dilute povidone-iodine remained significantly associated with a reduction in PJI. The absolute risk reduction was 0.73% and number needed to treat was 137 patients. Female gender, American Society of Anesthesiologists score, operative time, anesthesia type, prophylactic antibiotic type, and tranexamic acid were other significant factors in the regression model.
The routine use of dilute povidone-iodine could prevent 1 PJI for every 137 TJA patients, regardless of their preoperative risk. These findings support the use of povidone-iodine irrigation as a safe and cost-effective measure to reduce PJI.
全关节置换术(TJA)医生采用各种策略来降低假体周围关节感染(PJI)的风险。很少有研究在 TJA 近期实践变化的基础上,对大量队列中预闭合并使用稀释聚维酮碘冲洗的效果进行了评估。本研究比较了 TJA 患者使用和不使用稀释聚维酮碘冲洗的 PJI 风险。
这是一项对单机构 2009 年至 2019 年间所有连续初次 TJA 的回顾性研究。共纳入 31331 例患者,其中 8659 例使用稀释聚维酮碘冲洗,22672 例使用无菌生理盐水冲洗。主要终点为根据 2018 年国际共识会议标准定义的 PJI,最低随访 1 年。多变量逻辑回归用于确定稀释聚维酮碘冲洗与 PJI 之间的关联,同时控制人口统计学、合并症和手术因素。
共有 340 例患者(1.09%)发生 PJI。使用稀释聚维酮碘冲洗与 PJI 发生率降低 2.34 倍(0.6%比 1.3%)相关。使用多元回归,稀释聚维酮碘仍与 PJI 显著相关。绝对风险降低 0.73%,需要治疗的患者人数为 137 例。女性、美国麻醉医师协会评分、手术时间、麻醉类型、预防性抗生素类型和氨甲环酸是回归模型中的其他重要因素。
无论术前风险如何,常规使用稀释聚维酮碘冲洗可预防每 137 例 TJA 患者发生 1 例 PJI。这些发现支持使用聚维酮碘冲洗作为一种安全且具有成本效益的措施来降低 PJI 的发生率。